RT Journal Article
T1 De novo bone formation around implants with a surface based on a monolayer of multi‐phosphonate molecules. An experimental in vivo investigation
A1 Sanz Esporrín, Javier
A1 Di Raimondo, Riccardo
A1 Vignoletti, Fabio
A1 Núñez, Javier
A1 Muñoz, Fernando
A1 Sanz Alonso, Mariano
AB Objectives: The purpose of this experimental in vivo investigation was to evaluate the influence of modifying the implant surface by adding a monolayer of multiphosphonate molecules on the de novo bone formation and osseointegration.Material and Methods: The study was designed as an animal preclinical trial with intra-animal control and two healing periods, 2 and 8 weeks, to compare implants with an identical macro-design but with two different surfaces. Eight female Beagle dogs participated in the study. Control implants had a moderately rough surface combining sandblasting and acid etching; test implants had an additional monophosphonate layer covalently bonded to titanium. Histologic and radiographic (micro-CT) outcome variables were evaluated. Results: The first bone-to-implant contact (fBIC) was located more coronally for the test implants at the first (0.065 mm (95% CI = −0.82, 0.60)) and second healing milestones (0.17 mm (95% CI = −0.9, 0.55)). Most coronal BIC of the test implants displayed a higher percentage of osseointegration, +6.33% and +13.38% after 2 and 8 weeks, respectively; however, the differences were not statistically significant. The micro-CT examination did not show any BIC difference.Conclusions: The monophosphonate layer coating demonstrated clinical, histological, and radiographic results similar to the control surface.
PB Wiley
SN 0905-7161
YR 2021
FD 2021-06-17
LK https://hdl.handle.net/20.500.14352/8634
UL https://hdl.handle.net/20.500.14352/8634
LA eng
NO Sanz‐Esporrin J, Di Raimondo R, Vignoletti F, et al (2021) De novo bone formation around implants with a surface based on a monolayer of multi‐phosphonate molecules. An experimental in vivo investigation. Clinical Oral Implants Res 32:1085–1096. https://doi.org/10.1111/clr.13803
NO CRUE-CSIC (Acuerdos Transformativos 2021)
DS Docta Complutense
RD 13 abr 2025